Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Supply chain

UPS one of three companies awarded government contracts for 'express' medicines delivery service

The delivery company UPS is one of three transport firms to be given contracts worth a total of £25m to ensure medicines can be delivered quickly if Brexit goes ahead at the end of October 2019.

The Department of Health and Social Care (DHSC) has awarded the contracts to UPS, DFDS and Biocair, to provide access to a range of specialist services, including hand-delivered courier services if needed.

In a statement published on 16 October 2019, the DHSC said the service will provide delivery on small shipments, including temperature-controlled or hazardous products, within 24 hours or within 48 hours for larger shipments.

The service is expected to support the government’s “multi-layered” approach to Brexit contingency planning, which also includes stockpiling six weeks’ worth of medicines in the UK.

Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry, said the express freight service “is an important contingency plan that will help our members continue their preparations — alongside the stockpiles they have already built and alternative freight routes they have secured”.

Matt Hancock, the health and social care secretary, added that the service “will get urgent supplies and short-shelf-life medicines, like radioisotopes for cancer treatments, rapidly into the country, including by plane where necessary”.

“We now have detailed plans in place for every medicine — including those with short shelf lives,” he added.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207209

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.